Consensus on Harm Reduction Products: Results of EU Consultation

Business by 2FIRSTS.ai
Jan.17
Consensus on Harm Reduction Products: Results of EU Consultation
Global e-cigarette alliance (WVA) revealed EU citizens' consensus on harm reduction products' effectiveness in quitting smoking, urging policy reconsideration.

According to reports from Brussels media on January 15th, the World Vapers' Alliance (WVA) has recently released the latest results of the public consultation on the European Union Tobacco Products Directive (TPD). These results indicate a significant consensus among citizens, non-governmental organizations, and scientific institutions regarding the effectiveness of harm reduction products for smokers who wish to quit smoking.

 

According to public consultation data, 77% of respondents believe that harm reduction products are effective in helping smokers quit, with only 9% of EU citizens expressing opposition. Furthermore, as many as 82% of respondents disapprove the notion that new nicotine alternatives pose a risk to public health, with only 6% perceiving them as a threat.

 

Michael Landl, Director of the World Vapers' Alliance (WVA), expressed his concerns regarding the European Commission's current stance on harm reduction, stating that it not only lags behind but also blatantly disregards the perspective of consumers and scientific evidence. He emphasized the need for the Commission to acknowledge the fact that harm reduction products are not enemies, but rather crucial allies in the fight against smoking.

 

The successful harm reduction experiences in countries such as Sweden have become exemplars, highlighting the remarkable achievements of consumer-friendly harm reduction methods in reducing smoking rates. However, the European Commission's hostilities towards these approaches have been perplexing and have even had a negative impact on public health efforts.

 

Randall further pointed out: "Sweden's success story confirms the achievements that sensible harm reduction policies can bring. It is bewildering and even irresponsible that the European Commission continues to oppose these lifesaving products. The Commission should align its policies with clear evidence and public opinion, instead of clinging to outdated and ineffective approaches."

 

WVA urges the European Commission to reconsider its position and adopt a more evidence-based harm reduction approach, especially in the context of the upcoming Tobacco Products Directive (TPD) update. The recent consultation results should serve as a warning, emphasizing the urgency for policies that genuinely reflect public health and the needs of EU citizens.

 

Disclaimer: 
This article is translated from an original Chinese article available on 2firsts.cn by AI, and has been reviewed and edited by 2FIRSTS's English editorial team. The Chinese original text is the only authoritative source of information. The exclusive copyright and license rights to this article are held by 2FIRSTS Technology Co., Ltd. Any reproduction, reprinting, or redistribution of this article, either in part or in full, requires express written permission from 2FIRSTS and must include clear attribution along with a link to this content. Non-compliance may result in legal action. 2FIRSTS Technology Co., Ltd. reserves the right to pursue legal actions in case of unauthorized use or distribution.